An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis

Archive ouverte

Jönsson, Friederike | de Chaisemartin, Luc | Granger, Vanessa | Gouel-Chéron, Aurélie | Gillis, Caitlin | Zhu, Qianqian | Dib, Fadia | Nicaise-Roland, Pascale | Ganneau, Christelle | Hurtado-Nedelec, Maria | Paugam-Burtz, Catherine | Necib, Skander | Keita-Meyer, Hawa | Le Dorze, Matthieu | Cholley, Bernard | Langeron, Olivier | Jacob, Laurent | Plaud, Benoît | Fischler, Marc | Sauvan, Caroline | Guinnepain, Marie-Therese | Montravers, Philippe | Aubier, Michel | Bay, Sylvie | Neukirch, Catherine | Tubach, Florence | Longrois, Dan | Chollet-Martin, Sylvie | Bruhns, Pierre

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. Anaphylaxis is a systemic acute hypersensitivity reaction that is considered to depend on allergen-specific immunoglobulin E (IgE) antibodies and histamine release by mast cells and basophils. Nevertheless, allergen-specific IgG antibodies have been proposed to contribute when the allergen is an abundant circulating large molecule, e.g., after infusions of therapeutic antibodies or dextran. Data from animal models demonstrate a pathway involving platelet-activating factor (PAF) release by monocytes/macrophages and neutrophils activated via their Fc gamma receptors (FcγRs). We hypothesized that such a pathway may also apply to small drugs and could be responsible for non-IgE-mediated anaphylaxis and influence anaphylaxis severity in humans. We prospectively conducted a multicentric study of 86 patients with suspected anaphylaxis to neuromuscular-blocking agents (NMBAs) during general anesthesia and 86 matched controls. We found that concentrations of anti-NMBA IgG and markers of FcγR activation, PAF release, and neutrophil activation correlated with anaphylaxis severity. Neutrophils underwent degranulation and NETosis early after anaphylaxis onset, and plasma-purified anti-NMBA IgG triggered neutrophil activation ex vivo in the presence of NMBA. Neutrophil activation could also be observed in patients lacking evidence of classical IgE-dependent anaphylaxis. This study supports the existence of an IgG-neutrophil pathway in human NMBA-induced anaphylaxis, which may aggravate anaphylaxis in combination with the IgE pathway or underlie anaphylaxis in the absence of specific IgE. These results reconcile clinical and experimental data on the role of antibody classes in anaphylaxis and could inform diagnostic approaches to NMBA-induced acute hypersensitivity reactions.

Suggestions

Du même auteur

Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models

Archive ouverte | Dejoux, Alice | CCSD

International audience. Neuromuscular blocking agents (NMBAs) relax skeletal muscles to facilitate surgeries and ease intubation but can lead to adverse reactions, including complications because of postoperative re...

Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo

Archive ouverte | Dejoux, Alice | CCSD

International audience. BackgroundNeuromuscular blocking agents (NMBA) are muscle relaxants used to assist mechanical ventilation but lead in 1/10,000 anesthesia to severe acute hypersensitivity reactions i.e., anap...

Grade IV perioperative anaphylaxis to atracurium despite a previous negative skin test

Archive ouverte | Gouel-Chéron, Aurélie | CCSD

International audience

Chargement des enrichissements...